Vapotherm to Present at the Canaccord Genuity 40th Annual Growth Conference
August 06 2020 - 4:01PM
Business Wire
Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a
global medical technology company focused on the development and
commercialization of its proprietary high velocity therapy, which
is used to treat patients of all ages suffering from respiratory
distress, today announced that its management team will be
presenting at the Canaccord Genuity 40th Annual Growth Conference
on Thursday, August 13, 2020 via webcast.
Vapotherm is scheduled to present at 10:30 am Eastern Time. The
presentation will be accessible via a live webcast at:
http://wsw.com/webcast/canaccord42/vapo/.
A webcast replay of the presentation will be available for 90
days following the presentation in the Event Archive section of
Vapotherm’s Investor website at
http://investors.vapotherm.com/.
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded
developer and manufacturer of advanced respiratory technology based
in Exeter, New Hampshire, USA. The company develops innovative,
comfortable, non-invasive technologies for respiratory support of
patients with chronic or acute breathing disorders. Over 2.3
million patients have been treated with Vapotherm high velocity
therapy. For more information, visit www.vapotherm.com.
Vapotherm high velocity therapy is mask-free noninvasive
ventilatory support and is a front-line tool for relieving
respiratory distress—including hypercapnia, hypoxemia, and dyspnea.
It allows for the fast, safe treatment of undifferentiated
respiratory distress with one user-friendly tool. The Precision
Flow system’s mask-free interface delivers optimally conditioned
breathing gases, making it comfortable for patients and reducing
the risks and care complexities associated with mask therapies.
While being treated, patients can talk, eat, drink and take oral
medication.
Website Information Vapotherm routinely posts important
information for investors on the Investor Relations section of its
website, http://investors.vapotherm.com/. Vapotherm intends to use
this website as a means of disclosing material, non-public
information and for complying with Vapotherm’s disclosure
obligations under Regulation FD. Accordingly, investors should
monitor the Investor Relations section of Vapotherm’s website, in
addition to following Vapotherm’s press releases, Securities and
Exchange Commission filings, public conference calls, presentations
and webcasts. The information contained on, or that may be accessed
through, Vapotherm’s website is not incorporated by reference into,
and is not a part of, this document.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200806005896/en/
Investor Relations Contact: Mark Klausner or Mike Vallie,
Westwicke, an ICR Company, ir@vtherm.com, +1-(603)-658-0011
Vapotherm (NYSE:VAPO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vapotherm (NYSE:VAPO)
Historical Stock Chart
From Apr 2023 to Apr 2024